Author

Yimei Meng

Observed names: Meng, YF, Y. Meng

Institutions: Harbin Medical University, Jilin University, Second Affiliated Hospital of Harbin Medical University, University of Oklahoma

Observed institutions: Harbin Medical University, Jilin University, First Hospital of Jilin University, Zhejiang Provincial People's Hospital, Second Affiliated Hospital of Harbin Medical University, Wenzhou-Kean University, Shandong First Medical University, Hangzhou Medical College, University of Oklahoma

ORCID: 0000-0001-7489-5634

Observed ORCID: 0000-0001-7489-5634

OpenAlex ID: A5002293976

Acidosis activates breast cancer ferroptosis through ZFAND5/SLC3A2 signaling axis and elicits M1 macrophage polarization

2024 · Hanchu Xiong, Yanan Zhai, et al. · Cancer Letters · 66

Regulated cell death in cancer: Mechanisms, crosstalk, and opportunities for therapy

2025 · Yimei Meng, Qun Chen, et al. · Cancer Letters · 46

The role of DNA methylation in placental development and its implications for preeclampsia

2024 · Yizi Meng, Yimei Meng, et al. · Frontiers in Cell and Developmental Biology · 31

Tumor-immune-neural circuit disrupts energy homeostasis in cancer cachexia

2026 · Xiuhui Shi, Alex X. Arreola, et al. · Cancer Cell · 27

Advances in cfDNA research for pregnancy-related diseases

2025 · Yimei Meng, Yu Yan, et al. · Frontiers in Cell and Developmental Biology · 8

Assessment of lncRNA biomarkers based on NETs for prognosis and therapeutic response in ovarian cancer

2025 · Jingmeng Wang, Yusen Liang, et al. · Scientific Reports · 7

M6A modification mediates CACNA1A stability to drive the progression of ovarian cancer by inhibiting ferroptosis

2025 · Xieyang Gong, Jingmeng Wang, et al. · Journal of Ovarian Research · 3

IGF2BP3 regulates CACNA1A-Mediated Ferroptosis in Ovarian Cancer Through m6A Modification

2023 · Xieyang Gong, Anlong Jiang, et al. · SSRN Electronic Journal · 3

METTL2B m3C RNA transferase: oncogenic role in ovarian cancer progression via regulation of the mTOR/AKT pathway and its link to the tumor immune microenvironment

2024 · Yizi Meng, Yimei Meng, et al. · BMC Cancer · 2

The inhibition of acetylcholinesterase by a brain-targeting polylysine-ApoE peptide: biochemical and structural characterizations

2018 · L. Lu, T. M. Michelena, et al. · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · 2

The Effects of 24R, 25-dihydroxyvitamin D3 and 24S, 25-dihydroxyvitamin D3 on Phosphate Transport in Chicks In Vivo

2013 · Y. Meng, I. Nemere · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · 2

IPO9 Promotes Ovarian Cancer Progression by Suppressing HMOX1‐Dependent Ferroptosis

2026 · Yimei Meng, Peiling Li, et al. · Human Mutation · 1

Identification of a novel frameshift variation in ANKRD11: a case report of KBG syndrome

2025 · Qing Shao, Qiang Jiang, et al. · Frontiers in Genetics · 1

Histone H3K18 lactylation fuels MTHFD2-driven SAM biosynthesis to promote SPINT2 promoter hypermethylation and ovarian cancer progression

2026 · Yusen Liang, Yimei Meng, et al. · Oncogenesis

Characteristics of immobilized beta-galactosidase from Cicer arietinum

1997 · Li, XY, Meng, YF, et al. · Lanzhou University Institutional Repository

Works count: 15

Citation count: 199

H-index: 6

I10-index: 4